EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data

Ilya Lipkovich iD, David Svensson iD, Bohdana Ratitch iD, Alex Dmitrienko iD

Statistics in Medicine · 30.09.2024 · 43 (22) · 4388-4436

DOI: 10.1002/sim.10167 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Statistics in Medicine, online erschienen am 25.07.2024. Verfasst von Ilya Lipkovich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Analytics and Access Capabilities, Eli Lilly and Company, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Observational Studies as Topic, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 230 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this paper, we review recent advances in statistical methods for the evaluation of the heterogeneity of treatment effects (HTE), including subgroup identification and estimation of individualized treatment regimens, from randomized clinical trials and observational studies. We identify several types of approaches using the features introduced in Lipkovich et al ( Stat Med 2017;36: 136‐196) that distinguish the recommended principled methods from basic methods for HTE evaluation that typically rely on rules of thumb and general guidelines (the methods are often referred to as common practices). We discuss the advantages and disadvantages of various principled methods as well as common measures for evaluating their performance. We use simulated data and a case study based on a historical clinical trial to illustrate several new approaches to HTE evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Observational Studies as TopicRandomized Controlled Trials as TopicHumansTreatment OutcomeModels, StatisticalData Interpretation, StatisticalComputer SimulationTreatment Effect Heterogeneity

Stichwörter der Autor:innen

individualized treatment regimenpersonalized medicinesubgroup identification

Autor:innen und Institutionen

  • Advanced Analytics and Access Capabilities, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Statistical Innovation, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Clinical Statistics and Analytics, Research & Development, Pharmaceuticals, Bayer Inc., Mississauga, Ontario, Canada.
  • Department of Biostatistics, Mediana, San Juan, Puerto Rico, USA.

ORCID-Profile: Ilya Lipkovich, David Svensson, Bohdana Ratitch, Alex Dmitrienko

Zitieren

APA

Lipkovich, I., Svensson, D., Ratitch, B., & Dmitrienko, A. (2024). Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data. Statistics in Medicine, 43(22), 4388-4436. https://doi.org/10.1002/sim.10167

Vancouver

Lipkovich I, Svensson D, Ratitch B, Dmitrienko A. Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data. Statistics in Medicine. 2024;43(22):4388-4436. doi:10.1002/sim.10167

BibTeX
@article{Lipkovich2024,
  author = {Lipkovich, Ilya and Svensson, David and Ratitch, Bohdana and Dmitrienko, Alex},
  title = {Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data},
  journal = {Statistics in Medicine},
  year = {2024},
  volume = {43},
  number = {22},
  pages = {4388--4436},
  doi = {10.1002/sim.10167}
}
Kostenlos starten →